Information Provided By:
Fly News Breaks for November 13, 2019
Nov 13, 2019 | 07:35 EDT
Canaccord analyst Mark Massaro said the recent selloff in T2 Biosystems shares appears to be overdone. He noted the company delivered and inline quarter despite being having had ransom cyber-attack which lasted for several weeks and required the company to work in overdrive and perform manual operations for their business while seeking a remedy. He thinks the selloff is an over-reaction but Massaro lowered his price target to $3.00 from $3.50 on T2 Biosystems shares.
News For TTOO From the Last 2 Days
There are no results for your query TTOO